ifosfamide has been researched along with Duncan Disease in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients having rheumatoid arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (LPD)." | 3.81 | Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs. ( Fukayama, M; Koda, K; Tajima, S; Takanashi, Y, 2015) |
| " With a short apparent half-life (1." | 1.32 | Investigations on the pharmacokinetics of trofosfamide and its metabolites-first report of 4-hydroxy-trofosfamide kinetics in humans. ( Baumann, F; Niederwieser, D; Niemeyer, U; Pönisch, W; Preiss, R; Stefanovic, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tajima, S | 1 |
| Takanashi, Y | 1 |
| Koda, K | 1 |
| Fukayama, M | 1 |
| Sugino, N | 1 |
| Nakamura, C | 1 |
| Fujii, S | 1 |
| Matsui, Y | 1 |
| Kaneko, H | 1 |
| Watanabe, M | 1 |
| Miura, Y | 1 |
| Wakasa, T | 1 |
| Tsudo, M | 1 |
| Preiss, R | 1 |
| Baumann, F | 1 |
| Stefanovic, D | 1 |
| Niemeyer, U | 1 |
| Pönisch, W | 1 |
| Niederwieser, D | 1 |
| Mittal, S | 1 |
| Milner, BJ | 1 |
| Johnston, PW | 1 |
| Culligan, DJ | 1 |
| Williams, KM | 1 |
| Higman, MA | 1 |
| Chen, AR | 1 |
| Schwartz, CL | 1 |
| Wharam, M | 1 |
| Colombani, P | 1 |
| Arceci, RJ | 1 |
| O'Connell, N | 1 |
| Gardiner, N | 1 |
| Duggan, C | 1 |
| Enright, H | 1 |
| Kennedy, MJ | 1 |
| McCann, SR | 1 |
| Daly, PA | 1 |
| Browne, PV | 1 |
1 trial available for ifosfamide and Duncan Disease
| Article | Year |
|---|---|
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etopo | 2001 |
5 other studies available for ifosfamide and Duncan Disease
| Article | Year |
|---|---|
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Vi | 2015 |
[EBV-associated B-cell lymphoproliferative disorder of the elderly successfully treated with autologous peripheral blood stem cell transplantation and locoregional radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carboplatin; Combined Modality Therap | 2011 |
Investigations on the pharmacokinetics of trofosfamide and its metabolites-first report of 4-hydroxy-trofosfamide kinetics in humans.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Cyclophosphamide; F | 2004 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neop | 2006 |
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antine | 2008 |